ATP1A3 and epilepsy: The following studies further demonstrated that severe epilepsies have been reported in people with ATP1A3 mutations, and intellectual impairment may concomitantly occur with FHM and AHC (Paciorkowski et al., 2015; Liu et al., 2018).